Trastuzumab for patients with HER2 positive breast cancer: delivery, duration and combination therapies.
Auteurs : Pinto AC, Ades F, de Azambuja E, Piccart-Gebhart M
Jaar : 2013
Journal : Breast
Volume : 22 Suppl 2
Pagina's : S152-5